Democratic Republic of Congo vs India: Average cost of drugs for extensively drug-resistant tuberculosis

Democratic Republic of Congo

1,102 constant 2022 US$

in 2024

India

1,203 constant 2022 US$

in 2024

Democratic Republic of Congo rank

41st

India rank

39th

Average cost of drugs for extensively drug-resistant tuberculosis over time

Democratic Republic of Congo
India

How they compare

India currently reports 1,203 constant 2022 US$ against 1,102 constant 2022 US$ in Democratic Republic of Congo, a difference of 101 constant 2022 US$.

That makes India's figure about 1.1 times Democratic Republic of Congo's.

The two have swapped places 4 times across 8 shared years of data; in 2017 it was India ahead.

Democratic Republic of Congo ranks 41st and India ranks 39th of 56 countries.

Individual pages

About this data

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.